Literature DB >> 29045815

Eosinophils and eosinophil-associated diseases: An update.

Jeremy A O'Sullivan1, Bruce S Bochner2.   

Abstract

The goal of this series is to offer a survey of the latest literature for clinicians and scientists alike, providing a list of important recent advances relevant to the broad field of allergy and immunology. This particular assignment was to cover the topic of eosinophils. In an attempt to highlight major ideas, themes, trends, and advances relevant to basic and clinical aspects of eosinophil biology, a search of articles published since 2015 in the Journal of Allergy and Clinical Immunology and other high-impact journals was performed. Articles were then reviewed and organized, and then key findings were summarized. Given space limitations, many outstanding articles could not be included, but the hope is that what follows provides a succinct overview of recently published work that has significantly added to our knowledge of eosinophils and eosinophil-associated diseases.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eosinophilopoiesis; adipose tissue; apoptosis; asthma; biologicals; chronic rhinosinusitis with nasal polyposis; eosinophil subsets; eosinophilic gastrointestinal disorder; granule biogenesis; immunoregulation

Mesh:

Year:  2017        PMID: 29045815      PMCID: PMC5803328          DOI: 10.1016/j.jaci.2017.09.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  90 in total

1.  Phenotypic plasticity and targeting of Siglec-F(high) CD11c(low) eosinophils to the airway in a murine model of asthma.

Authors:  H Abdala Valencia; L F Loffredo; A V Misharin; S Berdnikovs
Journal:  Allergy       Date:  2015-10-20       Impact factor: 13.146

2.  Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.

Authors:  Andrew Blauvelt; Marjolein de Bruin-Weller; Melinda Gooderham; Jennifer C Cather; Jamie Weisman; David Pariser; Eric L Simpson; Kim A Papp; H Chih-Ho Hong; Diana Rubel; Peter Foley; Errol Prens; Christopher E M Griffiths; Takafumi Etoh; Pedro Herranz Pinto; Ramon M Pujol; Jacek C Szepietowski; Karel Ettler; Lajos Kemény; Xiaoping Zhu; Bolanle Akinlade; Thomas Hultsch; Vera Mastey; Abhijit Gadkari; Laurent Eckert; Nikhil Amin; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos; Brad Shumel
Journal:  Lancet       Date:  2017-05-04       Impact factor: 79.321

3.  Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.

Authors:  Eugene R Bleecker; J Mark FitzGerald; Pascal Chanez; Alberto Papi; Steven F Weinstein; Peter Barker; Stephanie Sproule; Geoffrey Gilmartin; Magnus Aurivillius; Viktoria Werkström; Mitchell Goldman
Journal:  Lancet       Date:  2016-09-05       Impact factor: 79.321

4.  Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.

Authors:  Evan S Dellon; David A Katzka; Margaret H Collins; Mohamed Hamdani; Sandeep K Gupta; Ikuo Hirano
Journal:  Gastroenterology       Date:  2016-11-23       Impact factor: 22.682

5.  Evidence for a role of eosinophils in blister formation in bullous pemphigoid.

Authors:  E de Graauw; C Sitaru; M Horn; L Borradori; S Yousefi; H-U Simon; D Simon
Journal:  Allergy       Date:  2017-03-01       Impact factor: 13.146

Review 6.  Biologics and biomarkers for asthma, urticaria, and nasal polyposis.

Authors:  Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2017-05       Impact factor: 10.793

7.  Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.

Authors:  Rinat Zaynagetdinov; Taylor P Sherrill; Linda A Gleaves; Allyson G McLoed; Jamie A Saxon; Arun C Habermann; Linda Connelly; Daniel Dulek; R Stokes Peebles; Barbara Fingleton; Fiona E Yull; Georgios T Stathopoulos; Timothy S Blackwell
Journal:  Cancer Res       Date:  2015-02-17       Impact factor: 12.701

8.  Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Gary T Ferguson; J Mark FitzGerald; Eugene R Bleecker; Michel Laviolette; David Bernstein; Craig LaForce; Lyndon Mansfield; Peter Barker; Yanping Wu; Maria Jison; Mitchell Goldman
Journal:  Lancet Respir Med       Date:  2017-05-22       Impact factor: 30.700

9.  Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Michael E Wechsler; Praveen Akuthota; David Jayne; Paneez Khoury; Amy Klion; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Maria C Cid; Raashid Luqmani; Judith Brown; Stephen Mallett; Richard Philipson; Steve W Yancey; Jonathan Steinfeld; Peter F Weller; Gerald J Gleich
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

10.  Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.

Authors:  Sally Wenzel; Mario Castro; Jonathan Corren; Jorge Maspero; Lin Wang; Bingzhi Zhang; Gianluca Pirozzi; E Rand Sutherland; Robert R Evans; Vijay N Joish; Laurent Eckert; Neil M H Graham; Neil Stahl; George D Yancopoulos; Mariana Louis-Tisserand; Ariel Teper
Journal:  Lancet       Date:  2016-04-27       Impact factor: 79.321

View more
  31 in total

Review 1.  Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.

Authors:  Mario Cazzola; Ermanno Puxeddu; Josuel Ora; Paola Rogliani
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

2.  Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 3.  Role of innate lymphoid cells in allergic diseases.

Authors:  M Asghar Pasha; Gargi Patel; Russell Hopp; Qi Yang
Journal:  Allergy Asthma Proc       Date:  2019-05-01       Impact factor: 2.587

4.  Evaluating prognostic value and relevant gene signatures of tumor microenvironment characterization in esophageal carcinoma.

Authors:  Wang Sheng; Xiaoyu Li; Jiayi Li; Yanjun Mi; Fan Li
Journal:  J Gastrointest Oncol       Date:  2021-08

5.  Clinical safety study of photobiomodulation in acute spinal cord injury by scattering fiber.

Authors:  Zhuowen Liang; Tao Lei; Shuang Wang; Pan Li; Beiyu Chen; Dongsheng Pan; Yongfeng Zhang; Xiaoshuang Zuo; Xuankang Wang; Zhuojing Luo; Xueyu Hu; Tan Ding; Zhe Wang
Journal:  Lasers Med Sci       Date:  2022-07-11       Impact factor: 2.555

6.  Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways.

Authors:  Caroline M Percopo; Julia O Krumholz; Elizabeth R Fischer; Laura S Kraemer; Michelle Ma; Karen Laky; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2018-10-04       Impact factor: 4.962

Review 7.  The emerging roles of eosinophils in mucosal homeostasis.

Authors:  Kathleen Shah; Aline Ignacio; Kathy D McCoy; Nicola L Harris
Journal:  Mucosal Immunol       Date:  2020-03-10       Impact factor: 7.313

8.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

Review 9.  The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Hans-Uwe Simon; Shida Yousefi; Nina Germic; Isabelle C Arnold; Angela Haczku; Alexander V Karaulov; Dagmar Simon; Helene F Rosenberg
Journal:  Int Arch Allergy Immunol       Date:  2019-11-29       Impact factor: 2.749

Review 10.  Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.

Authors:  Marco Mascitti; Lucrezia Togni; Corrado Rubini; Giuseppe Troiano; Lorenzo Lo Muzio; Andrea Santarelli
Journal:  Histol Histopathol       Date:  2020-09-28       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.